'Arcus Biosciences Set to Join S&P SmallCap 600,' Replacing Investors Bancorp -S&P Dow Jones Indices
$CFG
$ISBC
$RCUS
Major Banks
Finance
Savings Institutions
Finance
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/9/2026 | $65.00 | Neutral → Outperform | Robert W. Baird | |
| 2/12/2026 | $23.00 | Overweight → Equal Weight | Wells Fargo | |
| 1/13/2026 | $28.00 | Neutral → Buy | Goldman | |
| 1/8/2026 | $20.00 | Overweight → Equal-Weight | Morgan Stanley | |
| 1/7/2026 | $66.00 | Strong Buy → Outperform | Raymond James | |
| 1/5/2026 | $77.00 | Equal Weight → Overweight | Barclays | |
| 12/11/2025 | $60.00 | Outperform → Neutral | Robert W. Baird | |
| 10/9/2025 | $65.00 | Neutral → Buy | BofA Securities |
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer and inflammatory and autoimmune diseases, announced that its management team will host a conference call and webcast on Tuesday, May 5, 2026 at 1:30 PM PT / 4:30 PM ET to discuss details of the Company's financial results and pipeline updates for the quarter ended March 31st, 2026. Investors interested in listening to the conference call may do so by dialing +1 (585) 542-9983 (local) or +1 (833) 461-5787 (toll-free), using Meeting ID: 304747896. Participants may also register for the call online using the follow
Citizens Financial Group, Inc. (NYSE:CFG) announced today that Chairman and CEO Bruce Van Saun will participate at the Barclays Americas Select Franchise Conference to be held on Wednesday, May 6, 2026 at 2:15 pm GMT. The live webcast will be available at https://investor.citizensbank.com under Events & Presentations. About Citizens Financial Group, Inc. Citizens Financial Group, Inc. is one of the nation's oldest and largest financial institutions, with $227.9 billion in assets as of March 31, 2026. Headquartered in Providence, Rhode Island, Citizens offers a broad range of retail, private banking, wealth management and commercial banking products and services to individuals, small b
Positive Operating Leverage of 7.2% YoY Citizens Financial Group, Inc. (NYSE:CFG) today reported first quarter financial results. The earnings press release, investor presentation, and financial supplement are available at http://investor.citizensbank.com. In addition, these materials will be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K and will be available on the SEC website at www.sec.gov. "We are pleased to get off to a strong start in 2026 notwithstanding heightened geopolitical tensions and uncertainty in the macro environment," said Chairman and CEO Bruce Van Saun. "Our financial results in a seasonally soft quarter were good, with year-over-year EPS gr
4 - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Issuer)
4 - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Issuer)
4 - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Issuer)
Robert W. Baird upgraded Citizens Financial Group from Neutral to Outperform and set a new price target of $65.00
Wells Fargo downgraded Arcus Biosciences from Overweight to Equal Weight and set a new price target of $23.00
Goldman upgraded Arcus Biosciences from Neutral to Buy and set a new price target of $28.00
144 - Arcus Biosciences, Inc. (0001724521) (Subject)
DEFA14A - Arcus Biosciences, Inc. (0001724521) (Filer)
DEF 14A - Arcus Biosciences, Inc. (0001724521) (Filer)
4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)
SC 13G - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Subject)
SC 13G/A - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Subject)
Deal strengthens coverage of Downstream Energy & Convenience Retail sector Citizens Financial Group, Inc. (NYSE:CFG) today announced a definitive agreement to purchase substantially all the assets of Matrix Capital Markets Group, Inc., a market-leading advisory firm in the Downstream Energy & Convenience Retail sector, with additional expertise and proven success in the Automotive Aftermarket and Outdoor Recreation and Marine sectors. This transaction further strengthens Citizens' sector-focused advisory capabilities. Founded in 1988, Matrix has its headquarters in Richmond, VA, and a second office in Baltimore, MD, as well as bankers based in Cleveland and Atlanta, and serves clients a
Citizens Financial Group, Inc. (NYSE:CFG) today announced the appointment of Aunoy Banerjee as Executive Vice President and Chief Financial Officer. He will serve on the company's Executive Committee and report to Chairman and CEO Bruce Van Saun. Banerjee joins Citizens from Barclays, where he currently serves as CFO of Barclays Bank PLC, leading a large, global, multifunctional team supporting multiple lines of business including U.S. Consumer, Global Corporate and Investment Banking, and Private Bank and Wealth Management. Banerjee will join Citizens on October 24. As previously announced, current CFO John Woods will depart the bank on August 15. Chris Emerson, EVP and Head of Corporate
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that, in connection with the appointment of the Company's new Chief Medical Officer, Richard Markus, M.D., Ph.D., the Compensation Committee of the Company's Board of Directors granted Dr. Markus an option to purchase 305,328 shares of the Company's common stock at an exercise price per share of $12.45, which was the closing price on February 10, 2025, and restricted stock units to acquire a total of 75,193 shares of the Company's common stock. In addition to the awards to Dr. Markus, the Co
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer and inflammatory and autoimmune diseases, announced that its management team will host a conference call and webcast on Tuesday, May 5, 2026 at 1:30 PM PT / 4:30 PM ET to discuss details of the Company's financial results and pipeline updates for the quarter ended March 31st, 2026. Investors interested in listening to the conference call may do so by dialing +1 (585) 542-9983 (local) or +1 (833) 461-5787 (toll-free), using Meeting ID: 304747896. Participants may also register for the call online using the follow
Positive Operating Leverage of 7.2% YoY Citizens Financial Group, Inc. (NYSE:CFG) today reported first quarter financial results. The earnings press release, investor presentation, and financial supplement are available at http://investor.citizensbank.com. In addition, these materials will be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K and will be available on the SEC website at www.sec.gov. "We are pleased to get off to a strong start in 2026 notwithstanding heightened geopolitical tensions and uncertainty in the macro environment," said Chairman and CEO Bruce Van Saun. "Our financial results in a seasonally soft quarter were good, with year-over-year EPS gr
As previously announced, Citizens Financial Group, Inc. (NYSE:CFG) will report its first quarter 2026 earnings on April 16, 2026. The news release and supplemental materials will be available at http://investor.citizensbank.com. CFG management will host a live conference call that morning with details as follows: Time: 9:00 am (ET) Dial-in: To ask a question on the call, individuals may call in by dialing 800-369-1703, conference ID 1679767 For the listen only line, individuals may call in by dialing 800-475-8432, conference ID 7623330 Webcast/Presentation: The live webcast will be available at http://investor.citizensbank.com under Events & Pre